Peripheral Arterial Disease Trial, Recruiting (NCT06782100)

Peripheral Arterial Disease Trial, Recruiting NCT06782100 Sponsor: The Methodist Hospital Research Institute Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06782100 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older with peripheral artery disease (PAD) that causes rest pain, minor tissue loss, or significant wounds/gangrene (this is called Rutherford Category 4, 5, or 6 — confirm with trial site if unsure which category applies to you)
You must have at least one blocked or narrowed artery below the knee (in the lower leg) in one or both legs
The affected artery must be a certain size — between 2.0 and 4.0 mm wide, as estimated by the doctor
The affected artery must be narrowed by more than 50%, as estimated by the doctor

Who may not be able to join:

People whose peripheral artery disease is less severe (Rutherford categories 0, 1, 2, or 3 — meaning milder symptoms such as no symptoms, mild cramping, or moderate leg pain with walking)
People who are unwilling or unable to give written consent to take part in the study
People who cannot have an MRI scan (for example, due to certain metal implants or other medical reasons)
For one part of the study only (Aim 2): people who have a completely blocked artery (a total blockage with no blood flow through it) in the target area

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 713-441-5200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06782100

Sponsor: The Methodist Hospital Research Institute

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 713-441-5200

More information: https://clinicaltrials.gov/study/NCT06782100

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older with peripheral artery disease (PAD) that causes rest pain, minor tissue loss, or significant wounds/gangrene (this is called Rutherford Category 4, 5, or 6 — confirm with trial site if unsure which category applies to you)
You must have at least one blocked or narrowed artery below the knee (in the lower leg) in one or both legs
The affected artery must be a certain size — between 2.0 and 4.0 mm wide, as estimated by the doctor
The affected artery must be narrowed by more than 50%, as estimated by the doctor

Who may not be able to join:

People whose peripheral artery disease is less severe (Rutherford categories 0, 1, 2, or 3 — meaning milder symptoms such as no symptoms, mild cramping, or moderate leg pain with walking)
People who are unwilling or unable to give written consent to take part in the study
People who cannot have an MRI scan (for example, due to certain metal implants or other medical reasons)
For one part of the study only (Aim 2): people who have a completely blocked artery (a total blockage with no blood flow through it) in the target area

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Methodist Hospital Research Institute

Registry

ClinicalTrials.gov

Start date

1 July 2024

Est. completion

1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient primary Outcome; Amputation Arm Outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov